Aclaris Therapeutics

About Aclaris Therapeutics

Aclaris Therapeutics Inc. is a biopharmaceutical company focused on translating scientific discovery into therapeutic innovations for immuno-inflammatory conditions. Their mission is to empower patients by addressing underserved conditions with great ideas, relentless drive, and a passion for innovation.

Products & Services

Drug Development Pipeline:A pipeline of drugs under development for various conditions.

Investigational Drug Candidates:Candidates being researched for potential therapeutic use.

Clinical Trials:Ongoing trials to test the efficacy and safety of drug candidates.

Drug Discovery:Research efforts to identify new potential drugs.

Specialties

Immuno-inflammatory conditions Therapeutic innovation Drug development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 80000000 MR: - FA: $80.0 million FAN: 80000000	D: 2024-11-18 FD: 2024-11-18	8 investors

Private Placement Latest

2024-11-18

$80.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Marianne Mann

Pulmonologist and Drug Development Expert

Z

Zuzana Diamant

Pulmonologist and Clinical Pharmacologist

N

Neal Walker

Chief Executive Officer and Chair of Board of Directors

C

Christopher Molineaux

Lead Independent Director

H

Hugh Davis

President & Chief Operating Officer, Director

M

Maxine Gowen

Director

View 20 more team members with Pro

Unlock Full Team Directory

Recent News